The Terrible, Horrible, No Good, Very Bad Pharma Day*
A challenge You are passionate about providing an intervention (drug or device) to a group…
biotech
There are 59 articles under this tag
None Better than One? (A Brief Note on VC in Smaller Hubs)
Biotech venture funding metrics continue at historic highs, highlighting that the robust financing environment…
Blood: Underappreciated Resource in the Health/Disease?
Alternative title: Pitching a VC on Disruption of Blood Testing You may have seen…
Case Study: When does “technology” turn into medical device
This semester I've embarked on an adventure to co-teach a class in the University…
What is the optimal biotech burn rate?
Ethan Perlstein, founder of Perlstein Lab, asked a question on Twitter and got some great…
Innovation: Via a 5th Generation WI Life Science Company
I want to share three themes that struck me from the Dohmen Life Science Services…
Could Pharma/Biotech Build an Amazon?
Pharma/Biotech Business Model Innovation When I hear/read about business model innovation in pharma/biotech, the themes…
Experimenting in Academia: Indirect cost disruption?
Yesterday on Twitter I asked the following question and I wanted to follow up because…
Biotech: Outside Looking In
In a post in March, I suggested that I would represent the "less glamorous…
(Re)Reading This Weekend (6/14/14)
There were a few long reads that I'll be re-reading over the weekend, including: New…
Load More